Profil
Ji-Hoon Sohn is currently Chief Executive Officer & Director at PharmaResearch Co., Ltd. since 2025.
Formerly, Mr. Sohn was President, Co-Chief Executive Officer & Director at DONG WHA PHARM Co., Ltd. Mr. Sohn was Chief Executive Officer & Executive Director at Hugel, Inc. from 2018 to 2024.
Education includes an MBA from Boston University conferred in 1988 and an undergraduate degree from Korea University.
Aktive Positionen von Ji-Hoon Sohn
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMARESEARCH CO., LTD. | Vorstandsvorsitzender | 25.03.2025 |
Ehemalige bekannte Positionen von Ji-Hoon Sohn
| Unternehmen | Position | Ende |
|---|---|---|
| HUGEL, INC. | Vorstandsvorsitzender | - |
| DONGWHA PHARM.CO.,LTD | Vorstandsvorsitzender | - |
Ausbildung von Ji-Hoon Sohn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
DONG WHA PHARM Co., Ltd.
DONG WHA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicinal chemicals | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hugel, Inc.
Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
PharmaResearch Co., Ltd.
PharmaResearch Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology | Health Technology |
















